KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Capital Employed rose 800.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.06% for FY2024, which is 1200.0% down from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Return on Capital Employed is 0.03%, which was up 800.0% from 0.08% recorded in Q2 2025.
  • Pacira BioSciences' Return on Capital Employed's 5-year high stood at 0.09% during Q3 2021, with a 5-year trough of 0.08% in Q2 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.05% (2022), whereas its average is 0.03%.
  • Examining YoY changes over the last 5 years, Pacira BioSciences' Return on Capital Employed showed a top increase of 800bps in 2025 and a maximum decrease of -1400bps in 2025.
  • Quarter analysis of 5 years shows Pacira BioSciences' Return on Capital Employed stood at 0.08% in 2021, then crashed by -49bps to 0.04% in 2022, then skyrocketed by 56bps to 0.06% in 2023, then tumbled by -199bps to 0.06% in 2024, then surged by 153bps to 0.03% in 2025.
  • Its Return on Capital Employed stands at 0.03% for Q3 2025, versus 0.08% for Q2 2025 and 0.07% for Q1 2025.